DOCSLIB.ORG

Novel Concepts in Virology 2020 5–7 FEBRUARY 2020 | BARCELONA, SPAIN

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Novel Concepts in Virology 2020 5–7 FEBRUARY 2020 | BARCELONA, SPAIN viruses Novel Concepts in Virology 2020 5–7 FEBRUARY 2020 | BARCELONA, SPAIN Program Booklet Organizer Sponsors viruses Media Partners International Journal of Molecular Sciences reports biomedicines Partnering Societies WIFI: Auditori.axa PASSWORD: auditori96 Viruses 2020—Novel Concepts in Virology AXA Convention Centre Barcelona, Spain 5–7 February 2020 MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Organizing Committees Conference Chairs Dr. Eric O. Freed Dr. Albert Bosch Scientific Committee Dr. Graham F. Hatfull Dr. Michelle Flenniken Prof. Dr. K. Andrew White Dr. Susan Weiss Prof. Dr. Diane Griffin Organised by Conference Secretariat Dr. Sara Martinez Mr. Aimar Xiong Ms. Penny Zhang Email: [email protected] Welcome from the Chairs Dear Colleagues, It is with great pleasure that we announce the conference Viruses 2020—Novel Concepts in Virology to be held in Barcelona, Spain, 5‐7 February 2020. Because of their global impact on human, animal, and plant health and their utility as tractable model systems, viruses continue to play a central role in all aspects of biomedical research, ranging from molecular and cell biology, structural biology, and immunology to evolution, epidemiology, and bioinformatics. This conference will bring together leading virologists from around the world and across the broad field of virology to share results of their recent studies. Meeting participants will have the opportunity to present posters and short talks on their work and discuss their research in a stimulating and collegial environment. The conference is sponsored by MDPI, the publisher of the open‐access journal Viruses and follows the very successful meetings Viruses 2016—At the Forefront of Virus‐Host Interactions held in January 2016 in Basel, Switzerland and Viruses 2018—Breakthroughs in Viral Replication, held in February 2018 in Barcelona. We very much look forward to seeing you at this exciting meeting in Barcelona. Dr. Eric O. Freed Dr. Albert Bosch Conference Chair Conference Chair Table of Contents General Information 1 Invited Speakers 9 Program at a Glance 11 Conference Program 13 Poster Lists 19 Abstracts—Session 1 27 General Topics in Virology Abstracts—Session 2 43 Structural Virology Abstract—Session 3 51 Antiviral Innate Immunity Abstract—Session 4 65 Viral Pathogenesis Abstract—Session 5 79 Mechanisms of Virus Replication Abstract—Session 6 91 Viral Genetics and Evolution Abstracts—Poster Exhibition 103 General Information Viruses (ISSN 1999–4915; CODEN: VIRUBR) is a peer‐reviewed open access journal of virology, published monthly online by MDPI. The American Society for Virology (ASV), the Spanish Society for Virology (SEV), the Canadian Society for Virology (CSV), the Italian Society for Virology (SIV‐ISV), the Australasian Virology Society (AVS) and more societies are affiliated with Viruses and their members receive a discount on the article processing charges. Among other databases, Viruses is indexed by the Science Citation Index Expanded (Web of Science), MEDLINE (PubMed) and other databases. Full‐text available in PubMed Central. Journal Webpage: https://www.mdpi.com/journal/viruses Impact factor: 3.811 (2018) 5‐Year Impact Factor: 3.916 (2018) Viruses 2020—Novel Concepts in Virology 2 Conference Venue Auditorium AXA of the AXA Convention Centre Avinguda Diagonal, 547, 08029 Barcelona, Spain Registration Desk The desk for registration, information and distribution of documents will be open from 08:00 on 5 February 2020. Certificate of Attendance Upon request, the participants of the event will receive an electronic Certificate of Attendance by email once the event is concluded. Disclaimer Delegates will receive a name‐badge at the Information Desk, upon registration. The badge must be worn prominently in order to gain access to the congress area during all scientific and social events. Admission will be refused to anyone not in possession of an appropriate badge. Insurance The organizers do not accept liability for personal accident, loss, or damage to private property incurred as a result of participation in the Viruses 2020—Novels Concepts in Virology. Delegates are advised to arrange appropriate insurance to cover travel, cancellation costs, medical, and theft or damage of belongings. Emergency Information All emergencies in Spain: 112 (no area code needed) Ambulance (Ambulancia) and health emergencies: 061 or 112 Fire brigade (Cuerpo de bomberos): 080 or 112 Spanish National Police (Policía nacional): 091 Viruses 2020—Novel Concepts in Virology 3 Barcelona Barcelona is the capital and largest city of Catalonia and is Spain’s second largest city, with a population of over one and half million people. Located on the northeastern Mediterranean coast of Spain, this city has a rich and diverse history, with its roots dating back to Roman times. The fruitful medieval period established Barcelona’s position as the economic and political centre of the Western Mediterranean. The city’s Gothic Quarter bears witness to the splendour enjoyed by the city from the 13th to the 15th centuries. The 20th century ushered in widespread urban renewal throughout Barcelona city, culminating in its landmark Eixample district, which showcases some of Barcelona’s most distinctive Catalan art‐nouveau, or modernista, buildings. The Catalan Antoni Gaudí, one of the most eminent architects, designed buildings such as La Pedrera, the Casa Batlló and the Sagrada Família church, which have become world‐famous landmarks. In 1992, Barcelona gained international recognition by hosting the Olympic games which brought about a massive upturn in its tourism industry. For visitors, this has translated into the very modern, yet incredibly old city you see now in the 21st century, where new elements work to both preserve and celebrate both the city’s heritage and origins. Barcelona is plenty of outdoor markets, restaurants, shops, museums, and churches. The city is also very walkable, with an extensive and reliable Metro system for more far‐flung destinations. For a complete overview, see wikitravel.org or visit barcelonaturisme.com. Viruses 2020—Novel Concepts in Virology 4 The AXA Convention Centre The event will be held at the Auditorium AXA of the AXA Convention Centre, which is part of an enormous complex located on the main artery of Barcelona that integrates a shopping centre, two hotels, 48.000 m² of offices, a parking lot, two schools, a sport centre and a public park. City communications are excellent and access from Barcelona’s Airport and Sants Station is very quick. The avant‐garde design and construction quality emerge from each and every detail of the building, turning the l’ILLA complex into an emblematic reference of the city. AXA Convention Centre (Source: www.axa.es) As a whole, it is more than an auditorium: it is an infrastructure designed to offer quality, flexibility and integral attention through its wide range of services. How to Reach the Venue Address: Avinguda Diagonal, 547, 08029 Barcelona, Spain. Venue Location (Source: www.axa.es) Viruses 2020—Novel Concepts in Virology 5 Conference Dinner Thursday 6th February, 20:30 Price: 50€ Sold Out. To join the waiting list please ask at the Information Desk. The conference dinner will be held at La Camarga, a cutting‐edge restaurant specialized in Mediterranean cuisine with deep gastronomic roots that inspires dishes full of contemporary flavours and textures La Camarga is located at Carrer d’Aribau, 117, only a few minutes away from Passeig de Gràcia, one of the major avenues in Barcelona and one of its most important shopping and business areas, containing several of the city’s most celebrated pieces of architecture (such as La Pedrera or Casa Batlló).You can easily reach the restaurant either by taxi, bus or Metro. If you were to choose the second option, the closest metro stations are”Hospital Clinic” on Line 5 (blue), or”Diagonal” on Line 3 (green). Viruses 2020—Novel Concepts in Virology 6 Program Keynote Speakers Prof. Peter Palese Department of Microbiology Icahn School of Medicine at Mount Sinai, New York, NY, USA Invited Speakers Dr. Michelle Flenniken Dr. Cristina Risco Dr. Susan Weiss Montana State University, National Center for University of Pennsylvania, Bozeman, MT, USA Biotechnology, Philadelphia, PA, USA Madrid, Spain Prof. Rotem Sorek Prof. Diane E. Griffin Dr. Stacy M. Horner Weizmann Institute of Science, Johns Hopkins Bloomberg Duke University Medical Rehovot, Israel School of Public Health, Center, Durham, NC, USA Baltimore, MD, USA Viruses 2020—Novel Concepts in Virology 9 Dr. Graham F. Hatfull Prof. K. Andrew White Dr. Stanley M. Lemon University of Pittsburgh, York University, The University of North Pittsburgh, PA, USA Toronto, ON, Canada Carolina at Chapel Hill, Chapel Hill, NC, USA Dr. Marco Vignuzzi Prof. Martin Beer Dr. Jason McLellan Institut Pasteur, Institute of Diagnostic The University of Texas Paris, France Virology (IVD), at Austin, Greifswald, Insel Riems, Austin, TX, USA Germany Prof. Rosa M. Pintó University of Barcelona, Barcelona, Spain Viruses 2020—Novel Concepts in Virology 10 Program at a Glance Viruses 2020–Novel Concepts in Virology 5–7 February 2020, Barcelona, Spain Wednesday 5 February 2020 Thursday 6 February 2020 Friday 7 February 2020 Check‐in Opening Ceremony Session 3. Antiviral Innate Session 5. Mechanisms of Session 1. General Topics in Immunity Virus Replication Virology Morning Coffee Break Coffee Break Coffee Break (Conference Group Photo) Session 1. Part II Session 3. Part II Session 5. Part II Lunch
Load more

Recommended publications
  • Changes to Virus Taxonomy 2004
    Arch Virol (2005) 150: 189–198 DOI 10.1007/s00705-004-0429-1 Changes to virus taxonomy 2004 M. A. Mayo (ICTV Secretary) Scottish Crop Research Institute, Invergowrie, Dundee, U.K. Received July 30, 2004; accepted September 25, 2004 Published online November 10, 2004 c Springer-Verlag 2004 This note presents a compilation of recent changes to virus taxonomy decided by voting by the ICTV membership following recommendations from the ICTV Executive Committee. The changes are presented in the Table as decisions promoted by the Subcommittees of the EC and are grouped according to the major hosts of the viruses involved. These new taxa will be presented in more detail in the 8th ICTV Report scheduled to be published near the end of 2004 (Fauquet et al., 2004). Fauquet, C.M., Mayo, M.A., Maniloff, J., Desselberger, U., and Ball, L.A. (eds) (2004). Virus Taxonomy, VIIIth Report of the ICTV. Elsevier/Academic Press, London, pp. 1258. Recent changes to virus taxonomy Viruses of vertebrates Family Arenaviridae • Designate Cupixi virus as a species in the genus Arenavirus • Designate Bear Canyon virus as a species in the genus Arenavirus • Designate Allpahuayo virus as a species in the genus Arenavirus Family Birnaviridae • Assign Blotched snakehead virus as an unassigned species in family Birnaviridae Family Circoviridae • Create a new genus (Anellovirus) with Torque teno virus as type species Family Coronaviridae • Recognize a new species Severe acute respiratory syndrome coronavirus in the genus Coro- navirus, family Coronaviridae, order Nidovirales
    [Show full text]
  • Key Factors That Enable the Pandemic Potential of RNA Viruses and Inter-Species Transmission: a Systematic Review
    viruses Review Key Factors That Enable the Pandemic Potential of RNA Viruses and Inter-Species Transmission: A Systematic Review Santiago Alvarez-Munoz , Nicolas Upegui-Porras , Arlen P. Gomez and Gloria Ramirez-Nieto * Microbiology and Epidemiology Research Group, Facultad de Medicina Veterinaria y de Zootecnia, Universidad Nacional de Colombia, Bogotá 111321, Colombia; [email protected] (S.A.-M.); [email protected] (N.U.-P.); [email protected] (A.P.G.) * Correspondence: [email protected]; Tel.: +57-1-3-16-56-93 Abstract: Viruses play a primary role as etiological agents of pandemics worldwide. Although there has been progress in identifying the molecular features of both viruses and hosts, the extent of the impact these and other factors have that contribute to interspecies transmission and their relationship with the emergence of diseases are poorly understood. The objective of this review was to analyze the factors related to the characteristics inherent to RNA viruses accountable for pandemics in the last 20 years which facilitate infection, promote interspecies jump, and assist in the generation of zoonotic infections with pandemic potential. The search resulted in 48 research articles that met the inclusion criteria. Changes adopted by RNA viruses are influenced by environmental and host-related factors, which define their ability to adapt. Population density, host distribution, migration patterns, and the loss of natural habitats, among others, have been associated as factors in the virus–host interaction. This review also included a critical analysis of the Latin American context, considering its diverse and unique social, cultural, and biodiversity characteristics. The scarcity of scientific information is Citation: Alvarez-Munoz, S.; striking, thus, a call to local institutions and governments to invest more resources and efforts to the Upegui-Porras, N.; Gomez, A.P.; study of these factors in the region is key.
    [Show full text]
  • Detection of Epizootic Hemorrhagic Disease Virus Serotype 1, Israel
    RESEARCH LETTERS might lead to recruitment of more host and inflammatory 5. Joguet G, Mansuy JM, Matusali G, Hamdi S, Walschaerts M, cells that further amplify viral replication and organ injury Pavili L, et al. Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study. (6). Downregulation of several factors highlights the dam- Lancet Infect Dis. 2017;17:1200–8. http://dx.doi.org/10.1016/ age. For instance, the VEGF-A levels mirror the impair- S1473-3099(17)30444-9 ment of spermatogonia, primary spermatocytes, and Sertoli 6. Shi C, Pamer EG. Monocyte recruitment during infection and cells upon Zika virus infection (4). However, the decrease inflammation. Nat Rev Immunol. 2011;11:762–74. http://dx.doi.org/10.1038/nri3070 in CXCL-1, CXCL-8, and CXCL-10 levels in semen dur- 7. Rametse CL, Olivier AJ, Masson L, Barnabas S, McKinnon LR, ing infection could indicate a local immunosuppressive Ngcapu S, et al. Role of semen in altering the balance between state induced by infection, limiting immune cell infiltration inflammation and tolerance in the female genital tract: does in the MRT and potentially virus dissemination throughout it contribute to HIV risk? Viral Immunol. 2014;27:200–6. http://dx.doi.org/10.1089/vim.2013.0136 the body. 8. Fraczek M, Sanocka D, Kamieniczna M, Kurpisz M. The different kinetics of virus replication and cyto- Proinflammatory cytokines as an intermediate factor enhancing kine secretion in semen samples raises questions about the lipid sperm membrane peroxidation in in vitro conditions.
    [Show full text]
  • 2020 Taxonomic Update for Phylum Negarnaviricota (Riboviria: Orthornavirae), Including the Large Orders Bunyavirales and Mononegavirales
    Archives of Virology https://doi.org/10.1007/s00705-020-04731-2 VIROLOGY DIVISION NEWS 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales Jens H. Kuhn1 · Scott Adkins2 · Daniela Alioto3 · Sergey V. Alkhovsky4 · Gaya K. Amarasinghe5 · Simon J. Anthony6,7 · Tatjana Avšič‑Županc8 · María A. Ayllón9,10 · Justin Bahl11 · Anne Balkema‑Buschmann12 · Matthew J. Ballinger13 · Tomáš Bartonička14 · Christopher Basler15 · Sina Bavari16 · Martin Beer17 · Dennis A. Bente18 · Éric Bergeron19 · Brian H. Bird20 · Carol Blair21 · Kim R. Blasdell22 · Steven B. Bradfute23 · Rachel Breyta24 · Thomas Briese25 · Paul A. Brown26 · Ursula J. Buchholz27 · Michael J. Buchmeier28 · Alexander Bukreyev18,29 · Felicity Burt30 · Nihal Buzkan31 · Charles H. Calisher32 · Mengji Cao33,34 · Inmaculada Casas35 · John Chamberlain36 · Kartik Chandran37 · Rémi N. Charrel38 · Biao Chen39 · Michela Chiumenti40 · Il‑Ryong Choi41 · J. Christopher S. Clegg42 · Ian Crozier43 · John V. da Graça44 · Elena Dal Bó45 · Alberto M. R. Dávila46 · Juan Carlos de la Torre47 · Xavier de Lamballerie38 · Rik L. de Swart48 · Patrick L. Di Bello49 · Nicholas Di Paola50 · Francesco Di Serio40 · Ralf G. Dietzgen51 · Michele Digiaro52 · Valerian V. Dolja53 · Olga Dolnik54 · Michael A. Drebot55 · Jan Felix Drexler56 · Ralf Dürrwald57 · Lucie Dufkova58 · William G. Dundon59 · W. Paul Duprex60 · John M. Dye50 · Andrew J. Easton61 · Hideki Ebihara62 · Toufc Elbeaino63 · Koray Ergünay64 · Jorlan Fernandes195 · Anthony R. Fooks65 · Pierre B. H. Formenty66 · Leonie F. Forth17 · Ron A. M. Fouchier48 · Juliana Freitas‑Astúa67 · Selma Gago‑Zachert68,69 · George Fú Gāo70 · María Laura García71 · Adolfo García‑Sastre72 · Aura R. Garrison50 · Aiah Gbakima73 · Tracey Goldstein74 · Jean‑Paul J. Gonzalez75,76 · Anthony Grifths77 · Martin H. Groschup12 · Stephan Günther78 · Alexandro Guterres195 · Roy A.
    [Show full text]
  • Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
    Hindawi Publishing Corporation Scienti�ca Volume 2012, Article ID 478631, 22 pages http://dx.doi.org/10.6064/2012/478631 Review Article Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis Peter Karayiannis Section of Hepatology and Gastroenterology, Department of Medicine, Imperial College, St Mary’s Campus, London W2 1PG, UK Correspondence should be addressed to Peter Karayiannis; [email protected] Received 17 September 2012; Accepted 8 October 2012 Academic Editors: M. Clementi and W. Vogel Copyright © 2012 Peter Karayiannis. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. e development and evaluation of antiviral agents through carefully designed clinical trials over the last 25 years have heralded a new dawn in the treatment of patients chronically infected with the hepatitis B and C viruses, but not so for the D virus (HBV, HCV, and HDV). e introduction of direct acting antivirals (DDAs) for the treatment of HBV carriers has permitted the long- term use of these compounds for the continuous suppression of viral replication, whilst in the case of HCV in combination with the standard of care [SOC, pegylated interferon (PegIFN), and ribavirin] sustained virological responses (SVRs) have been achieved with increasing frequency. Progress in the case of HDV has been slow and lacking in signi�cant breakthroughs.is paper aims to summarise the current state of play in treatment approaches for chonic viral hepatitis patients and future perspectives. 1. Introduction recombinant subsequently, both of which have more recently been superceded by the pegylated form (PegIFN), which Conservative estimates of the number of individuals world- requires intramuscular injection only once a week as opposed wide who are thought to be chronically infected with either to three times a week with the previous forms.
    [Show full text]
  • Topics in Viral Immunology Bruce Campell Supervisory Patent Examiner Art Unit 1648 IS THIS METHOD OBVIOUS?
    Topics in Viral Immunology Bruce Campell Supervisory Patent Examiner Art Unit 1648 IS THIS METHOD OBVIOUS? Claim: A method of vaccinating against CPV-1 by… Prior art: A method of vaccinating against CPV-2 by [same method as claimed]. 2 HOW ARE VIRUSES CLASSIFIED? Source: Seventh Report of the International Committee on Taxonomy of Viruses (2000) Edited By M.H.V. van Regenmortel, C.M. Fauquet, D.H.L. Bishop, E.B. Carstens, M.K. Estes, S.M. Lemon, J. Maniloff, M.A. Mayo, D. J. McGeoch, C.R. Pringle, R.B. Wickner Virology Division International Union of Microbiological Sciences 3 TAXONOMY - HOW ARE VIRUSES CLASSIFIED? Example: Potyvirus family (Potyviridae) Example: Herpesvirus family (Herpesviridae) 4 Potyviruses Plant viruses Filamentous particles, 650-900 nm + sense, linear ssRNA genome Genome expressed as polyprotein 5 Potyvirus Taxonomy - Traditional Host range Transmission (fungi, aphids, mites, etc.) Symptoms Particle morphology Serology (antibody cross reactivity) 6 Potyviridae Genera Bymovirus – bipartite genome, fungi Rymovirus – monopartite genome, mites Tritimovirus – monopartite genome, mites, wheat Potyvirus – monopartite genome, aphids Ipomovirus – monopartite genome, whiteflies Macluravirus – monopartite genome, aphids, bulbs 7 Potyvirus Taxonomy - Molecular Polyprotein cleavage sites % similarity of coat protein sequences Genomic sequences – many complete genomic sequences, >200 coat protein sequences now available for comparison 8 Coat Protein Sequence Comparison (RNA) 9 Potyviridae Species Bymovirus – 6 species Rymovirus – 4-5 species Tritimovirus – 2 species Potyvirus – 85 – 173 species Ipomovirus – 1-2 species Macluravirus – 2 species 10 Higher Order Virus Taxonomy Nature of genome: RNA or DNA; ds or ss (+/-); linear, circular (supercoiled?) or segmented (number of segments?) Genome size – 11-383 kb Presence of envelope Morphology: spherical, filamentous, isometric, rod, bacilliform, etc.
    [Show full text]
  • Producing Vaccines Against Enveloped Viruses in Plants: Making the Impossible, Difficult
    Review Producing Vaccines against Enveloped Viruses in Plants: Making the Impossible, Difficult Hadrien Peyret , John F. C. Steele † , Jae-Wan Jung, Eva C. Thuenemann , Yulia Meshcheriakova and George P. Lomonossoff * Department of Biochemistry and Metabolism, John Innes Centre, Norwich NR4 7UH, UK; [email protected] (H.P.); [email protected] (J.F.C.S.); [email protected] (J.-W.J.); [email protected] (E.C.T.); [email protected] (Y.M.) * Correspondence: [email protected] † Current address: Piramal Healthcare UK Ltd., Piramal Pharma Solutions, Northumberland NE61 3YA, UK. Abstract: The past 30 years have seen the growth of plant molecular farming as an approach to the production of recombinant proteins for pharmaceutical and biotechnological uses. Much of this effort has focused on producing vaccine candidates against viral diseases, including those caused by enveloped viruses. These represent a particular challenge given the difficulties associated with expressing and purifying membrane-bound proteins and achieving correct assembly. Despite this, there have been notable successes both from a biochemical and a clinical perspective, with a number of clinical trials showing great promise. This review will explore the history and current status of plant-produced vaccine candidates against enveloped viruses to date, with a particular focus on virus-like particles (VLPs), which mimic authentic virus structures but do not contain infectious genetic material. Citation: Peyret, H.; Steele, J.F.C.; Jung, J.-W.; Thuenemann, E.C.; Keywords: alphavirus; Bunyavirales; coronavirus; Flaviviridae; hepatitis B virus; human immunode- Meshcheriakova, Y.; Lomonossoff, ficiency virus; Influenza virus; newcastle disease virus; plant molecular farming; plant-produced G.P.
    [Show full text]
  • THE POSSIBLE ROLE of ENDOGENOUS RETROVIRUSES in TUMOUR DEVELOPMENT & INNATE SIGNALLING by EMMANUEL ATANGANA MAZE a Thesis Su
    University of Plymouth PEARL https://pearl.plymouth.ac.uk 04 University of Plymouth Research Theses 01 Research Theses Main Collection 2018 THE POSSIBLE ROLE OF ENDOGENOUS RETROVIRUSES IN TUMOUR DEVELOPMENT AND INNATE SIGNALLING Atangana Maze, Emmanuel http://hdl.handle.net/10026.1/13081 University of Plymouth All content in PEARL is protected by copyright law. Author manuscripts are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author. THE POSSIBLE ROLE OF ENDOGENOUS RETROVIRUSES IN TUMOUR DEVELOPMENT & INNATE SIGNALLING by EMMANUEL ATANGANA MAZE A thesis submitted to the University of Plymouth in partial fulfilment for the degree of DOCTOR OF PHILOSOPHY School of Biomedical Sciences 2018 COPYRIGHT STATEMENT This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognize that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without the author’s prior consent. 2 THE POSSIBLE ROLE OF ENDOGENOUS RETROVIRUSES IN TUMOUR DEVELOPMENT & INNATE SIGNALLING by EMMANUEL ATANGANA MAZE UNIVERSITY OF PLYMOUTH School of Biomedical Sciences 2018 3 “You are the light of the world. A town built on a hill cannot be hidden. Neither do people light a lamp and put it under a bowl. Instead they put it on its stand, and it gives light to everyone in the house.
    [Show full text]
  • Virus-Host Interaction: the Multifaceted Roles of Ifitms And
    Virus-Host Interaction: The Multifaceted Roles of IFITMs and LY6E in HIV Infection DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Jingyou Yu Graduate Program in Comparative and Veterinary Medicine The Ohio State University 2018 Dissertation Committee: Shan-Lu Liu, MD, PhD, Advisor Patrick L. Green, PhD Jianrong Li, DVM., PhD Jesse J. Kwiek, PhD Copyrighted by Jingyou Yu 2018 Abstract With over 1.8 million newly infected people each year, the worldwide HIV-1 epidemic remains an imperative challenge for public health. Recent work has demonstrated that type I interferons (IFNs) efficiently suppress HIV infection through induction of hundreds of interferon stimulated genes (ISGs). These ISGs target distinct infection stages of invading pathogens and shape innate immunity. Among these, interferon induced transmembrane proteins (IFITMs) and lymphocyte antigen 6 complex, locus E (LY6E) have been shown to differentially modulate viral infections. However, their effects on HIV are not fully understood. In my thesis work, I provided evidence in Chapter 2 showing that IFITM proteins, particularly IFITM2 and IFITM3, specifically antagonize the HIV-1 envelope glycoprotein (Env), thereby inhibiting viral infection. IFITM proteins interacted with HIV-1 Env in viral producer cells, leading to impaired Env processing and virion incorporation. Notably, the level of IFITM incorporation into HIV-1 virions did not strictly correlate with the extent of inhibition. Prolonged passage of HIV-1 in IFITM-expressing T lymphocytes led to emergence of Env mutants that overcome IFITM restriction. The ability of IFITMs to inhibit cell-to-cell infection can be extended to HIV-1 primary isolates, HIV-2 and SIVs; however, the extent of inhibition appeared to be virus- strain dependent.
    [Show full text]
  • A Look Into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins
    viruses Review A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins Shanna S. Leventhal, Drew Wilson, Heinz Feldmann and David W. Hawman * Laboratory of Virology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA; [email protected] (S.S.L.); [email protected] (D.W.); [email protected] (H.F.) * Correspondence: [email protected]; Tel.: +1-406-802-6120 Abstract: In 2016, the Bunyavirales order was established by the International Committee on Taxon- omy of Viruses (ICTV) to incorporate the increasing number of related viruses across 13 viral families. While diverse, four of the families (Peribunyaviridae, Nairoviridae, Hantaviridae, and Phenuiviridae) contain known human pathogens and share a similar tri-segmented, negative-sense RNA genomic organization. In addition to the nucleoprotein and envelope glycoproteins encoded by the small and medium segments, respectively, many of the viruses in these families also encode for non-structural (NS) NSs and NSm proteins. The NSs of Phenuiviridae is the most extensively studied as a host interferon antagonist, functioning through a variety of mechanisms seen throughout the other three families. In addition, functions impacting cellular apoptosis, chromatin organization, and transcrip- tional activities, to name a few, are possessed by NSs across the families. Peribunyaviridae, Nairoviridae, and Phenuiviridae also encode an NSm, although less extensively studied than NSs, that has roles in antagonizing immune responses, promoting viral assembly and infectivity, and even maintenance of infection in host mosquito vectors. Overall, the similar and divergent roles of NS proteins of these Citation: Leventhal, S.S.; Wilson, D.; human pathogenic Bunyavirales are of particular interest in understanding disease progression, viral Feldmann, H.; Hawman, D.W.
    [Show full text]
  • Origins and Evolution of the Global RNA Virome
    bioRxiv preprint doi: https://doi.org/10.1101/451740; this version posted October 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Origins and Evolution of the Global RNA Virome 2 Yuri I. Wolfa, Darius Kazlauskasb,c, Jaime Iranzoa, Adriana Lucía-Sanza,d, Jens H. 3 Kuhne, Mart Krupovicc, Valerian V. Doljaf,#, Eugene V. Koonina 4 aNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA 5 b Vilniaus universitetas biotechnologijos institutas, Vilnius, Lithuania 6 c Département de Microbiologie, Institut Pasteur, Paris, France 7 dCentro Nacional de Biotecnología, Madrid, Spain 8 eIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious 9 Diseases, National Institutes of Health, Frederick, Maryland, USA 10 fDepartment of Botany and Plant Pathology, Oregon State University, Corvallis, Oregon, USA 11 12 #Address correspondence to Valerian V. Dolja, [email protected] 13 14 Running title: Global RNA Virome 15 16 KEYWORDS 17 virus evolution, RNA virome, RNA-dependent RNA polymerase, phylogenomics, horizontal 18 virus transfer, virus classification, virus taxonomy 1 bioRxiv preprint doi: https://doi.org/10.1101/451740; this version posted October 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 19 ABSTRACT 20 Viruses with RNA genomes dominate the eukaryotic virome, reaching enormous diversity in 21 animals and plants. The recent advances of metaviromics prompted us to perform a detailed 22 phylogenomic reconstruction of the evolution of the dramatically expanded global RNA virome.
    [Show full text]
  • Characterization of Antibodies to Human Immunodeficiency Viral Proteins in the Sera of HIV Infected and Non HIV Infected Hbsag Seropositive Patients
    Global Journal of Health Science Vol. 2, No. 1; April 2010 Characterization of Antibodies to Human Immunodeficiency Viral Proteins in the Sera of HIV Infected and Non HIV Infected HBsAg Seropositive Patients Dr. Mathew Folaranmi OLANIYAN (Ph. D) School of Medical Laboratory Technology, Baptist Medical Centre P.M. B. 43, Saki – Oyo State, Nigeria Tel: 234-805-224-8019 E-mail: [email protected] Abstract This work was designed to characterize the HIV viral antibodies in HIV infected and non-HIV infected HBsAg seropositive patients. Fifty non HIV infected (male = 25; female = 25)and 50 HIV infected HBsAg seropositive patients (male – n = 25; female – n = 25) aged 6 – 64 years recruited from the medical outpatient department of Baptist Medical Centre, Saki – Oyo State – Nigeria were investigated as test subjects. Fifty apparently healthy HIV and HBsAg seronegative individuals (male = 25; female = 25) aged 4 – 72years were recruited as control subjects. All subjects were counseled and were subjected to HBsAg and HIV immunoassays by Enzyme Linked Immunosorbent Assay and Western blot assay. All subjects were monitored for twelve months. The subjects were investigated on recruitment and 12months after recruitment. The result obtained indicated higher frequency of occurrence of each of the HIV antibodies to each of the viral proteins in HIV infected HBsAg seropositive patients than in non HIV infected HBsAg seropositive patients (94% vs 0% (gp 160,), 84% vs 0% (gp 120), 94% vs 4% (p66), 94% vs 4% (p51), 84% vs 0% (gp 41), 94% vs 0% (p31), 100% vs 24% (p24) and 84% vs 6% (p17) during the first bleeding.
    [Show full text]